Literature DB >> 7976385

[Evaluation of theophylline population pharmacokinetics in adult hospitalized patients using NONMEM analysis].

Z Li1, G Chen.   

Abstract

The population pharmacokinetics of theophylline was evaluated using 374 theophylline serum concentration measurements from 72 hospitalized patients through NONMEM analysis. An one-compartment open pharmacokinetic model with first-order absorption and first-order elimination was used. The effects of a variety of factors on Cl and Vd were investigated. Hypothesis testing to evaluated potentially significant factors produced a final regression model. There were about 1.25% per year decrease in Cl at the age of 18-77. Cl was reduced by 26.8% for patients with long history of theophylline administration and multiple dosings, and reduced by 33.9% in OLD patients. Sex, body weight, and coadministration of acetylspiramycin had no significant effects on Cl. Vd was proportional to body weight. The final regression model allowed a priori estimate of the theophylline pharmacokinetic parameters in the patients. These results may be helpful to a rational individualized theophylline dosage regimen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7976385

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  3 in total

1.  Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers.

Authors:  P J Tiseo; K Foley; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

2.  Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease.

Authors:  Yanjiao Ma; Ling Xue; Xin Chen; Yingbo Kang; Yong Wang; Liqing Wang
Journal:  Int J Clin Pharm       Date:  2018-05-18

3.  Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.

Authors:  A Navid; D M Ng; S E Wong; F C Lightstone
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.